1. You Are At:
  2. Home
  3. India News
  4. Oxytocin formulations ban to come into effect from 1st July

Oxytocin formulations ban to come into effect from 1st July

The Oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, i.e. KAPL, to the registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail Chemist.

Edited by: India TV News Desk, New Delhi [ Updated: June 28, 2018 8:18 IST ]
Image Source : AP

Representational

The Ministry of Health and Family Welfare has restricted the manufacture of Oxytocin formulations for domestic use to public sector only from 1st July. It has also banned the import of Oxytocin and its formulations.

From 1st July, no private manufacturer will be allowed to manufacture the drug for domestic use. Only Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL), a public sector company, would be manufacturing this drug for domestic use from that date. The Oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, i.e. KAPL, to the registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail chemists.

All the registered hospitals and clinics in public and private sector in the country are advised to contact KAPL and place their orders with the company as the drug will not be available with retail chemists or any other manufacturer.

As a medication, Oxytocin is used to cause contraction of the uterus in order to start labor. It is also used to increase the speed of labor and to stop bleeding following delivery. It is given by injection either into a muscle or into a vein.

Write a comment

Live Scorecard